CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Holdings History for Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN)

Symbol: VRDN on Nasdaq
Investment type: Equity / Common Stock, $0.01 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$23,307,666	748,961	+153,600	+26%	$31.12	Q4 2025
30 Sep 2025	0%	+0%	$12,847,890	595,361	+21,340	+3.7%	$21.58	Q3 2025
30 Jun 2025	0%	+0%	$8,024,814	574,021	+8,058	+1.4%	$13.98	Q2 2025
31 Mar 2025	0%	-0%	$7,629,181	565,963	-9,107	-1.6%	$13.48	Q1 2025
31 Dec 2024	0%	+0%	$11,024,092	575,070	+58,857	+11%	$19.17	Q4 2024
30 Sep 2024	0%	+0%	$11,743,846	516,213	+32,292	+6.7%	$22.75	Q3 2024
30 Jun 2024	0%	+0%	$6,295,812	483,921	+59,836	+14%	$13.01	Q2 2024
31 Mar 2024	0%	+0%	$7,425,728	424,085	+52,774	+14%	$17.51	Q1 2024
31 Dec 2023	0%	+0%	$8,087,154	371,311	+58,094	+19%	$21.78	Q4 2023
30 Sep 2023	0%	+0%	$4,804,749	313,217	+197,430	+171%	$15.34	Q3 2023
30 Jun 2023	0%	+0%	$2,754,573	115,787	+11,717	+11%	$23.79	Q2 2023
31 Mar 2023	0%	+0%	$2,647,541	104,070	+1,830	+1.8%	$25.44	Q1 2023
31 Dec 2022	0%	+0%	$2,986,430	102,240	+28,691	+39%	$29.21	Q4 2022
30 Sep 2022	0%	+0%	$1,509,000	73,549	+5,303	+7.8%	$20.52	Q3 2022
30 Jun 2022	0%	+0%	$790,000	68,246	+68,246	NEW	$11.58	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.